Wieckowska et al. [114], for example, reported a strong positive correlation between CK-18 in plasma obtained from patients with suspected NAFLD at the time of liver biopsy and hepatic damage. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.